Neurology

COVID-19: Telemedicine Gets Real, Real Fast Across Neurology In the face of COVID-19, neurologists working in stroke, epilepsy, dementia, and other subspecialties are tasked with a quick pivot from in-office patient visits to a new era of online consultations.
News, March 28, 2020
More Evidence Points to Acupuncture's Benefit for Migraine Although research has shown little difference between manual and sham acupuncture, use of a nonpenetrating sham intervention in acupuncture-naïve subjects could explain a new study's positive results.
News, March 27, 2020
An Aspirin a Day Does Not Keep Dementia at Bay Daily low-dose aspirin as prevention therapy takes another hit, this time for not reducing risk of Alzheimer's disease or cognitive impairment in a large randomized study.
News, March 27, 2020
COVID-19 and Angiotensin Drugs: Help or Harm? The controversy about whether ACE inhibitors and angiotensin blockers may affect COVID-19 infection continues, with hypotheses suggesting these drugs may both help or harm the situation.
News, March 25, 2020
COVID-19: AAN Urges Feds to Further Expand Telehealth Benefits In the face of the COVID-19 pandemic, the American Academy of Neurology is calling on the federal government to do more to expand telehealth services beyond Medicare.
News, March 23, 2020
ORION: Inclisiran Phase 3 Trials Published Three phase 3 trials of the novel RNA agent have been published, all showing an approximate halving of LDL cholesterol levels with the drug, which is given just twice a year by subcutaneous injection.
News, March 18, 2020
Surgery Cuts Chronic Sciatica Pain vs Conservative Treatment Surgery is superior to conservative treatment for chronic sciatica caused by lumbar disc herniation.
News, March 18, 2020
Long-Term Stroke Rate After TAVR: New Data A new registry study has shown a high rate of stroke mortality in the few years following TAVR, but the authors suggest this may be because of the high-risk population included.
News, March 16, 2020
Topline Results Disappoint for Biotin in Progressive MS A pharmaceutical-grade biotin product (MD1003) tested for progressive MS did not meet primary or secondary endpoints in a phase 3 study designed to confirm positive results of an earlier trial.
News, March 11, 2020
Smartphone Use Connected to More Severe Headaches Smartphone use in patients with primary headache is connected to more medication use and less pain relief, new research shows.
News, March 04, 2020
Vegetarian Diet Linked to Lower Stroke Risk A vegetarian diet rich in nuts, vegetables, and soy has been linked to a lower risk of both ischemic and hemorrhagic stroke, new research suggests.
News, March 03, 2020
High Failure Rate for Magnetic Rod System in Scoliosis Surgery Authors recommend that surgeons gradually stretch the spine when using the magnetic rod system in kids with scoliosis
News, February 14, 2020
'Milestone' Discovery Offers Hope for Life-Threatening Disorders The discovery that an antibody is linked to a wider range of autoimmune diseases than previously thought offers new hope for children with life-threatening neurologic disorders.
News, February 12, 2020
Seminal, Highly Anticipated Alzheimer's Trial Falters Top-line results from the phase 2/3 DIAN-TU trial show that neither of two investigational drugs met primary or key secondary outcomes in patients with dominantly inherited Alzheimer's disease.
News, February 11, 2020
Best Treatment for Post-Stroke Depression Still Unclear Choosing the best treatment option for post-stroke depression is still more art than science, with little evidence to support one approach over another, a new Cochrane review shows.
News, February 07, 2020
AI Blood Test Predicts Neurodegenerative Disease Progression A novel machine-learning tool that uses genetic data from patient blood samples can strongly predict the progression and severity of neurodegenerative diseases such as Alzheimer's and Huntington's.
News, February 07, 2020
New Data Rank Neurologic Diagnoses by Suicide Risk A small but significant increase in risk for death by suicide occurs in the months immediately following diagnosis of specific neurologic disorders, results of a large, population-based study show.
News, February 04, 2020
Alert FDA Expands Clearance for OTC Pain Device The FDA has expanded marketing clearance for the ActiPatch, an over-the-counter electromagnetic neuromodulation device, for the adjunctive treatment of musculoskeletal pain.
News, February 04, 2020
Blood Pressure Key to Good Outcomes in Stroke Thrombectomy Both low and high levels of blood pressure during endovascular treatment for acute ischemic stroke are associated with poor functional outcome, a new study suggests.
News, February 03, 2020
Seminal NEJM Ambulatory BP Study Retracted: Now What? The study was said to be the largest ever conducted of ABPM and showed the technique to predict all-cause mortality. So what now?
News, January 30, 2020

Neurology

About

Membership

Apps

WebMD Network

Editions

Neurology

Find Us On

About

Membership

Apps

WebMD Network

Editions